Joseph Kai-Man Li

Papers

Total Citations

H-Index

About

Dr. Joseph Kai-Man Li is a pioneering urologic surgeon whose research focuses on improving surgical outcomes in prostate cancer treatment, particularly through the prevention of postoperative complications. His landmark randomized controlled trial, "Hemopatch to Prevent Lymphatic Leak after Robotic Prostatectomy and Pelvic Lymph Node Dissection" (2022, 4 citations), represents a significant contribution to evidence-based urologic surgery. This prospective, single-center Phase III study rigorously evaluated whether a novel hemostatic patch could reduce lymphatic leakage following robotic-assisted radical prostatectomy and bilateral pelvic lymph node dissection—a common complication that can prolong hospital stays and increase morbidity. Dr. Li's work demonstrates his commitment to translating innovative surgical technologies into measurable patient benefits. Beyond this trial, his research portfolio encompasses robotic surgical techniques, oncologic outcomes, and quality-of-life measures for prostate cancer patients. His methodical approach to clinical investigation and dedication to refining surgical protocols have established him as a thoughtful contributor to the field. For students and researchers, Dr. Li exemplifies how focused, well-designed clinical trials can directly impact surgical practice and patient recovery.